131 related articles for article (PubMed ID: 12117288)
21. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
Waldmann E; Parhofer KG
Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
[TBL] [Abstract][Full Text] [Related]
22. Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system.
Tani N
Artif Organs; 1996 Aug; 20(8):922-9. PubMed ID: 8853808
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of long-term lipid apheresis at a single center.
Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
[TBL] [Abstract][Full Text] [Related]
24. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
Moriarty P; Sosland R; Gibson C; Belmont J
Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.
Otto C; Kern P; Bambauer R; Kallert S; Schwandt P; Parhofer KG
Artif Organs; 2003 Dec; 27(12):1116-22. PubMed ID: 14678426
[TBL] [Abstract][Full Text] [Related]
26. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U
Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304
[TBL] [Abstract][Full Text] [Related]
27. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
[TBL] [Abstract][Full Text] [Related]
28. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
29. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
30. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
32. Short- and long-term effects on serum lipoproteins by three different techniques of apheresis.
Richter WO; Donner MG; Schwandt P
Artif Organs; 1996 Apr; 20(4):311-7. PubMed ID: 8860712
[TBL] [Abstract][Full Text] [Related]
33. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of lipids and lipoproteins with determination of the recovery rate in the non-steady state following plasma, membrane filtration and dextran sulfate adsorption apheresis in hypercholesterolemia].
Schwartzkopff W; Gräfenhahn H; Nold A; von Baeyer H; Bimmermann A; Schleicher J
Biomed Tech (Berl); 1989 Oct; 34(10):232-42. PubMed ID: 2479419
[TBL] [Abstract][Full Text] [Related]
35. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
Otto C; Berster J; Otto B; Parhofer KG
J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
[TBL] [Abstract][Full Text] [Related]
36. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
37. State of the art of lipid apheresis.
Bosch T
Artif Organs; 1996 Apr; 20(4):292-5. PubMed ID: 8860709
[TBL] [Abstract][Full Text] [Related]
38. Protein adsorption during LDL-apheresis: proteomic analysis.
Dihazi H; Koziolek MJ; Söllner T; Kahler E; Klingel R; Neuhoff R; Strutz F; Mueller GA
Nephrol Dial Transplant; 2008 Sep; 23(9):2925-35. PubMed ID: 18398017
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal immunoadsorption treatment for rheumatoid arthritis.
Hailey D; Topfer LA
Issues Emerg Health Technol; 2002 Jan; (28):1-4. PubMed ID: 11968222
[TBL] [Abstract][Full Text] [Related]
40. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.
Grützmacher P; Landgraf H; Esser R; Okon J; Vlachojannis J; Ehrly AM; Schoeppe W
ASAIO Trans; 1990; 36(3):M327-30. PubMed ID: 2252691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
